Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 105 Records) |
| Query Trace: Death and ALK[original query] |
|---|
| Prognosis and oncogenomic profiling of patients with tropomyosin receptor kinase fusion cancer in the 100,000 genomes project. Cancer treatment and research communications 2022 Aug 33 100623. Bridgewater John, Jiao Xiaolong, Parimi Mounika, Flach Clare, Stratford Jeran, Kamburov Atanas, Schmitz Arndt A, Zong Jihong, Reeves John A, Keating Karen, Bruno Amanda, Fellous Marc, Pereira Mariana Buongermino, Bazhenova Lyudmi |
| Whole exome sequencing of high-risk neuroblastoma identifies novel non-synonymous variants. PloS one 2022 17 (8): e0273280. Przyby?a Weronika, Gjersvoll Paulsen Kirsti Marie, Mishra Charitra Kumar, Nygård Ståle, Engebretsen Solveig, Ruud Ellen, Trøen Gunhild, Beiske Klaus, Baumbusch Lars Oliv |
| Targeted Therapies and Utility of the Lung-molGPA in Non-Small-Cell Lung Cancer Patients with Brain Metastases. Oncology 2022 8 100 (10): 542-554. Cacho-Díaz Bernardo, Cuapantécatl Laura D, Garcilazo-Reyes Ytel J, Cabrera-Miranda Luis, Hernandez-Martinez Juan-Manuel, Arrieta Osc |
| Five-Year Overall Survival and Prognostic Factors in Patients with Lung Cancer: Results from the Korean Association of Lung Cancer Registry (KALC-R) 2015. Cancer research and treatment 2022 7 55 (1): 103-111. Jeon Da Som, Kim Ho Cheol, Kim Se Hee, Kim Tae-Jung, Kim Hong Kwan, Moon Mi Hyung, Beck Kyongmin Sarah, Suh Yang-Gun, Song Changhoon, Ahn Jin Seok, Lee Jeong Eun, Lim Jeong Uk, Jeon Jae Hyun, Jung Kyu-Won, Jung Chi Young, Cho Jeong Su, Choi Yoo-Duk, Hwang Seung-Sik, Choi Chang-Min, , |
| Genomic Features of Solid Tumor Patients Harboring ALK/ROS1/NTRK Gene Fusions. Frontiers in oncology 2022 7 12 813158. Dai Yinghuan, Liu Ping, He Wenlong, Yang Lizhen, Ni Yang, Ma Xuejiao, Du Furong, Song Chao, Liu Yang, Sun |
| Prognosis of ALK-rearranged non-small-cell lung cancer patients carrying TP53 mutations. Translational oncology 2022 7 23 101471. Canale Matteo, Petracci Elisabetta, Cravero Paola, Mariotti Marita, Minuti Gabriele, Metro Giulio, Ludovini Vienna, Baglivo Sara, Puccetti Maurizio, Dubini Alessandra, Martinelli Giovanni, Delmonte Angelo, Crinò Lucio, Ulivi Pao |
| A lung adenocarcinoma patient with co-mutations of MET and EGFR exon20 insertion responded to crizotinib. BMC medical genomics 2022 Jun 15 (1): 141. Chen Yan, Jiang Bo, He Yuange, Zhang Chu, Zhou Wenjie, Fang Cheng, Gu Dejian, Zhang Minxia, Ji Mei, Shi Juntao, Yang X |
| Actionable mutations in non-small cell lung cancer in patients at hospital de Especialidades Eugenio Espejo, Ecuador 2017-2020. Drug metabolism and personalized therapy 2022 12 . Fernández Freire Miguel Ángel, Gálvez Salazar Gabriela Isabel, Scudeler Mariana Meira, Rodrigues-Soares Fernanda, Jaramillo Koupermann Gabriela Fernanda, Moreno Ocampo Andrea Pao |
| An open label, safety study of Asian patients with advanced non-small-cell lung cancer receiving second-line nivolumab monotherapy (CheckMate 870). Therapeutic advances in medical oncology 2022 11 14 17588359221138380. Lu Shun, Cheng Ying, Zhou Jianying, Wang Mengzhao, Zhao Jun, Wang Baocheng, Chen Gongyan, Feng Jifeng, Ma Zhiyong, Wu Lin, Wang Changli, Ma Kewei, Zhang Shucai, Liang Jun, Song Yong, Wang Jie, Wu Yi-Long, Li Ang, Huang Yizhi, Chang Jianh |
| Toripalimab Plus Chemotherapy for Patients With Treatment-Naive Advanced Non-Small-Cell Lung Cancer: A Multicenter Randomized Phase III Trial (CHOICE-01). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2022 10 41 (3): 651-663. Wang Zhijie, Wu Lin, Li Baolan, Cheng Ying, Li Xiaoling, Wang Xicheng, Han Liang, Wu Xiaohong, Fan Yun, Yu Yan, Lv Dongqing, Shi Jianhua, Huang Jianjin, Zhou Shaozhang, Han Baohui, Sun Guogui, Guo Qisen, Ji Youxin, Zhu Xiaoli, Hu Sheng, Zhang Wei, Wang Qiming, Jia Yuming, Wang Ziping, Song Yong, Wu Jingxun, Shi Meiqi, Li Xingya, Han Zhigang, Liu Yunpeng, Yu Zhuang, Liu An-Wen, Wang Xiuwen, Zhou Caicun, Zhong Diansheng, Miao Liyun, Zhang Zhihong, Zhao Hui, Yang Jun, Wang Dong, Wang Yingyi, Li Qiang, Zhang Xiaodong, Ji Mei, Yang Zhenzhou, Cui Jiuwei, Gao Beili, Wang Buhai, Liu Hu, Nie Lei, He Mei, Jin Shi, Gu Wei, Shu Yongqian, Zhou Tong, Feng Jian, Yang Xinmei, Huang Cheng, Zhu Bo, Yao Yu, Tang Xiongwen, Yu Jianjun, Maher Ellen, Feng Hui, Yao Sheng, Keegan Patricia, Wang J |
| Utility of multigene panel next-generation sequencing in routine clinical practice for identifying genomic alterations in newly diagnosed metastatic nonsmall cell lung cancer. Internal medicine journal 2023 9 . Udit Nindra, Abhijit Pal, Victoria Bray, Po Y Yip, Annette Tognela, Tara L Roberts, Therese M Becker, Jonathon Williamson, Mahtab Farzin, Jing J Li, Vivienne Lea, Abeer Hagelamin, Weng Ng, Bin Wang, C Soon Lee, Wei Ch |
| Compromised Outcomes in Stage IV Non-Small-Cell Lung Cancer With Actionable Mutations Initially Treated Without Tyrosine Kinase Inhibitors: A Retrospective Analysis of Real-World Data. JCO oncology practice 2023 8 OP2200611. Jeffrey A Scott, Jochen Lennerz, Melissa Lynne Johnson, Lucio N Gordan, Robert H Dumanois, Luca Quagliata, Lauren L Ritterhouse, Federico Cappuzzo, Brandon Wang, Mei Xue, Anupama Vasudevan, Prateesh Varughese, Varun Vaidya, Mike Gart, Natalie Dorrow, Hinco J Gierman, Rushir J Chok |
| Common driver mutations and programmed death-ligand 1 expression in advanced non-small cell lung cancer in smokers and never smokers. BMC cancer 2023 7 23 (1): 659. Chong Kin Liam, Chian Yih Yew, Yong Kek Pang, Chee Kuan Wong, Mau Ern Poh, Jiunn Liang Tan, Chun Ian Soo, Thian Chee Loh, Ka Kiat Chin, Vijayan Munusamy, Yong Sheng Liam, Nur Husna Ibrah |
| Outcome of Children and Adolescents With Relapsed/Refractory/Progressive Malignancies Treated With Molecularly Informed Targeted Drugs in the Pediatric Precision Oncology Registry INFORM. JCO precision oncology 2023 6 7 e2300015. Anna-Elisa Heipertz, Kristian W Pajtler, Elke Pfaff, Kathrin Schramm, Mirjam Blattner-Johnson, Till Milde, Barbara C Jones, Cecilia Zuliani, Caroline Hutter, Olli Lohi, Antonis Kattamis, Iwona Dachowska-Kalwak, Anna Nilsson, Nicolas U Gerber, Karin P S Langenberg, Bianca Goemans, C Michel Zwaan, Jan J Molenaar, Natalie Jäger, Uta Dirksen, Ruth Witt, Stefan M Pfister, David T W Jones, Annette Kopp-Schneider, Olaf Witt, Cornelis M van Tilbu |
| Association of PD-L1 expression with efficacy of alectinib in advanced NSCLC patients with ALK fusion. Lung cancer (Amsterdam, Netherlands) 2023 5 181 107233. Yingying Pan, Xinyu Liu, Wei Zhang, Wanying Wang, Haowei Wang, Libo Luo, Keyi Jia, Chuchu Shao, Shiqi Mao, Tianyu Qiu, Jun Ni, Jia Yu, Lei Wang, Bin Chen, Anwen Xiong, Guanghui Gao, Xiaoxia Chen, Fengying Wu, Caicun Zhou, Chunyan Wu, Shengxiang R |
| A systematic review of genetic ancestry as a risk factor for incidence of non-small cell lung cancer in the US. Frontiers in genetics 2023 4 14 1141058. Breanna A James, Jennie L Williams, Barbara Nemesu |
| Overall survival in patients with advanced non-small cell lung cancer with KRAS G12C mutation with or without STK11 and/or KEAP1 mutations in a real-world setting. BMC cancer 2023 4 23 (1): 352. Julian Cristina, Pal Navdeep, Gershon Anda, Evangelista Marie, Purkey Hans, Lambert Peter, Shi Zhen, Zhang Qi |
| PDL1 and molecular biomarkers expression in non-small cell lung cancer in Tunisian patients. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace 2023 11 . Yoldez Houcine, Chirine Moussa, Ahmed Ben Abdelaziz, Aida Aya |
| Associations of tissue tumor mutational burden and mutational status with clinical outcomes in KEYNOTE-042: pembrolizumab versus chemotherapy for advanced PD-L1-positive NSCLC. Annals of oncology : official journal of the European Society for Medical Oncology 2023 1 . Mok T S K, Lopes G, Cho B C, Kowalski D M, Kasahara K, Wu Y-L, de Castro G, Turna H Z, Cristescu R, Aurora-Garg D, Loboda A, Lunceford J, Kobie J, Ayers M, Pietanza M C, Piperdi B, Herbst R |
| Evaluation of the novel International Association for the Study of Lung Cancer grading system in adenocarcinoma with spread through air space. Translational lung cancer research 2024 9 13 (8): 1862-1876. Kuan Xu, Yilv Lv, Tangbing Chen, Yuchen Han, Hanqing Huang, Hong Yu, Bo |
| The influence of nutritional status, lipid profile, leptin concentration and polymorphism of genes encoding leptin and neuropeptide Y on the effectiveness of immunotherapy in advanced NSCLC patients. BMC cancer 2024 8 24 (1): 937. Ma?gorzata Fr?k, Anna Grenda, Pawe? Krawczyk, Barbara Ku?nar-Kami?ska, Pawe? Pazdrowski, Karolina K?dra, Izabela Chmielewska, Janusz Milanows |
| Association of PD-L1 expression and clinical outcomes in ROS1 - rearranged advanced non-small cell lung cancer treated with crizotinib. Frontiers in oncology 2024 6 14 1405683. Huixian Zhang, Ziheng Zhang, Ningning Yan, Xingya |
| Multi-index comprehensive evaluation of the efficacy and response mechanism of immunotherapy in non-small cell lung cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2024 6 . Jieqiong Fan, Tao Zha |
| Immunotherapy for patients with advanced non-small cell lung cancer harboring oncogenic driver alterations other than EGFR: a multicenter real-world analysis. Translational lung cancer research 2024 5 13 (4): 861-874. Tian Tian, Yanying Li, Juan Li, Hongyu Xu, Hua Fan, Jiang Zhu, Yongsheng Wang, Feng Peng, Youling Gong, Yijia Du, Xiaoyan Yan, Xiulan He, Ayse Ece Cali Daylan, Andreas Pircher, Shane S Neibart, Yusuke Okuma, Min Hee Hong, Meijuan Huang, You |
| Prognostic Value of KRAS/TP53 Status for Overall Survival in First-Line Monoimmunotherapy and Chemoimmunotherapy Treated Patients With Nonsquamous NSCLC in the Netherlands: A Brief Report. JTO clinical and research reports 2024 12 5 (12): 100745. Vincent D de Jager, Léon C van Kempen, Betzabel N Cajiao Garcia, T Jeroen N Hiltermann, Anthonie J van der Wekken, Ed Schuuring, Stefan M Wille |
| Clinical utility and predictive value of cerebrospinal fluid cell-free DNA profiling in non-small cell lung cancer patients with leptomeningeal metastasis. Neoplasia (New York, N.Y.) 2024 12 60 101113. Sheng-Kai Liang, Wei-Yu Liao, Jin-Yuan Shih, Chia-Lin Hsu, Ching-Yao Yang, Shang-Gin Wu, Yen-Ting Lin, Yueh-Feng Wen, Lun-Che Chen, Yen-Fu Chen, Ya-Fang Chen, Yen-Heng Lin, Chong-Jen |
| Evaluation of the efficacy of PD?1/PD?L1 inhibitor plus bevacizumab and chemotherapy for the treatment of patients with driver gene?negative advanced?stage lung adenocarcinoma: A retrospective cohort study. Oncology letters 2024 11 29 (1): 53. Xiaozun Yang, Xin Li, Ke Huang, Xiang Zhua |
| The Prevalence of Programmed Death Ligand-1 (PD-L1) Expression in Non-Small Cell Lung Cancer: An Experience From Tertiary Care Hospital. Cureus 2024 11 16 (10): e72291. Asmita Mehta, Lakshmi Priya V P, Lakshmi Teja, Krishna Pill |
| Epidemiological and clinical characteristics of lung cancer in Saudi Arabia: a retrospective study in single oncology center. Oncology research 2024 10 32 (11): 1803-1809. Yousef Katib, Nasser Mul |
| Impact of select actionable genomic alterations on efficacy of neoadjuvant immunotherapy in resectable non-small cell lung cancer. Journal for immunotherapy of cancer 2024 10 12 (10): . Nicolas Zhou, Cheuk H Leung, William N William, Annikka Weissferdt, Apar Pataer, Myrna C B Godoy, Brett W Carter, Frank V Fossella, Anne S Tsao, George R Blumenschein, Xiuning Le, Jianjun Zhang, Ferdinandos Skoulidis, Jonathan M Kurie, Mehmet Altan, Charles Lu, Bonnie S Glisson, Lauren A Byers, Yasir Y Elamin, Reza J Mehran, David C Rice, Garrett L Walsh, Wayne L Hofstetter, Jack A Roth, Hai T Tran, Jia Wu, Luisa M Solis Soto, Humam Kadara, Stephen G Swisher, Ara A Vaporciyan, Don L Gibbons, Heather Y Lin, J Jack Lee, John V Heymach, Marcelo V Negrao, Boris Sepesi, Tina Casco |
- Page last reviewed:Feb 1, 2024
- Content source: